Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

TNGX Tango Therapeutics Inc

3,52

0,47 (15,41%)

Nach Börsenschluss

Zuletzt aktualisiert: 23:31:57

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Tango Therapeutics (NASDAQ:TNGX)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Tango Therapeutics Charts.

Tango Therapeutics (NASDAQ:TNGX)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Tango Therapeutics Charts.

News Tango Therapeutics Inc

Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Donnerstag 2 Januar 2025 (5 Tage vor) • Edgar (US Regulatory)

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dienstag 3 Dezember 2024 (1 Monat vor) • Business Wire

Tango Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference
Mittwoch 27 November 2024 (1 Monat vor) • Business Wire

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Mittwoch 20 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 19 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Freitag 8 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 6 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 6 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Tango Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Highlights
Mittwoch 6 November 2024 (2 Monate vor) • Business Wire

Tango Therapeutics Reports Positive TNG462 Clinical Data and Provides Update on PRMT5 Development Program
Mittwoch 6 November 2024 (2 Monate vor) • Business Wire

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Montag 28 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Tango Therapeutics Inc News-Artikel

Health Care Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen